Monday, April 6, 2020

Monthly Archives: October 2016

Popular Articles

Core Innovation Capital raises biggest fund to date, $100m goal in sight

FinTech venture capital investor Core Innovation Capital is withing sight of its fundraising goal for its third flagship vehicle after hauling in more than $80m.

Another strong Elysian Capital exit sees firm return 4.5x from Wellbeing investment

Elysian Capital has scored a 4.5x return on investment by selling Wellbeing Software to Australian trade buyer The Citadel Group for £103m.

These nine US venture capital firms are dominating the AI investment push

US venture capital firms are betting big on the potential of AI investments - and have secured a pretty significant domination of the sector, new research shows.

Coronavirus strikes debut Ikhlas Capital fundraise, firm said to reassess $500m goal

Singapore private equity house Ikhlas Capital is reportedly reassessing its planned $500m goal for its debut fundraise due to the worsening coronavirus crisis across the globe.

Silver Lake said to eye coronavirus buying opportunity by launching $16bn tech fundraise

Tech-focused private equity major Silver Lake is planning to brave the current coronavirus-affected fundraising market by attempting to raise at least $16bn for a new flagship buyout fund, it has emerged.

Palatine PE picks managed IT provider Acora as latest buy-and-build investment

UK-based Palatine Private Equity has backed Acora, a managed IT services provider, as it looks to expand its service capabilities through a buy-and-build strategy.

Insight Partners powers to $9.5bn Fund XI close, less than two years after raising...

Less than two years after closing its tenth flagship fund on $6.3bn, Insight Partners has hit a huge $9.5bn final close for its latest flagship software investment fund.

Biopharma backer VenBio soars past Fund III target to reach $394m final close

Biopharma development investor VenBio Partners has soared past its target for its third life sciences fundraise to close the vehicle on about $394m.

CVC powers to $4.5bn hard cap in fifth Asia-Pacific private equity fundraise

CVC Capital Partners has hit the $4.5bn hard cap for the final close of its fifth private equity fund targeting the Asia-Pacific region.The buyout...

Morgan Stanley Capital Partners sells Pathway Vet Alliance stake to TSG

Morgan Stanley Capital Partners has sold a majority stake in Pathway Vet Alliance to TSG Consumer Partners.

Get the latest PE News & Research delivered to your inbox every morning